Open AccessIdentification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
Author(s) -
Sergio Forcelloni,
A. Benedetti,
Maddalena Dilucca,
Andrea Giansanti
Publication year - 2021
Publication title -
current genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 64
eISSN - 1875-5488
pISSN - 1389-2029
DOI - 10.2174/1389202923666211216162605
Subject(s) - epitope , heptad repeat , coronavirus , glycoprotein , virology , biology , conserved sequence , epitope mapping , peptide sequence , antibody , computational biology , genetics , covid-19 , gene , medicine , disease , pathology , infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus that first occurred in Wuhan in December 2019. The spike glycoproteins and nucleocapsid proteins are the most common targets for the development of vaccines and antiviral drugs.